OBSESSIVE COMPULSIVE DISORDER (OCD)

BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD

BrainsWay OCD – a noninvasive, innovative treatment – is transforming the treatment of OCD. It offers an effective, safe and non-invasive treatment that uses Deep Transcranial Magnetic Stimulation to treat OCD. The treatment performs magnetic stimulation of frontal brain structures and networks, targeting previously unreachable areas of the brain with its proprietary H7-coil, allowing it to effectively treat OCD. BrainsWay OCD has many advantages over other treatment options, as it is an outpatient procedure that is generally well tolerated and entails minimal side effects.

BrainsWay OCD therapy can significantly improve patients suffering from OCD, as was demonstrated in the positive results of BrainsWay’s Deep-TMS study, the only multicenter trial in OCD patients ever conducted.

The multicenter study demonstrated that after six weeks of treatment, there was a statistically significant improvement in the primary endpoint results for the active treatment group when compared to sham (p=0.0127). The improvement was maintained one month after the end of treatment at week 10. The primary outcome measure of this study was the OCD Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), the gold standard measure of OCD symptoms severity. Importantly, 38.1% of patients in the active group achieved a response of more than 30% reduction in symptoms severity as measured by Y-BOCS, compared with just 11.1% in the sham group (p=0.0033). Moreover, 54.8% of patients in the active group achieved a partial response of more than 20% reduction in symptoms severity, versus just 26.7% in the sham group (p=0.0076).

ocd

Find a provider
near you

Lorem ipsum dolor sit amet consectetur adipiscing elit